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or that these markers are not necessarily cartilage specific and
could play similar or novel role in bone remodeling. Furthermore,
the robust regulation of chondrogenic markers in bone and their
good correlation to BMD & BMC suggest that they could be good
predictors of disease and treatment outcomes.
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Purpose: There is consensus that osteoarthritis (OA) is char-
acterized by subchondral bone thickening, accompanied by an
increased osteoid volume and a low mineralization. Until now,
phenotypical changes occurring in osteoblasts from the sclerotic
subchondral bone remains unexplored. This work was designed
to compare gene expression in osteoblasts coming from the
sclerotic and non sclerotic zones of human OA subchondral
bone.
Methods: Human osteoblasts were isolated from sclerotic or
non sclerotic areas of OA subchondral bone. They were cultured
for 12 days in monolayer in a differentiation medium composed
of 2% Ultroser G as serum substitute, 2 mM proline, 50 micro-
gram/ml ascorbic acid and 10-8 M 1,25 dihydroxycalciferol. At
the end of this differentiation period, gene expression in sclerotic
or non sclerotic osteoblasts was compared. Tissue non specific
alkaline phosphatase (TNAP), osteocalcin (OC), transforming
growth factor -beta1 (TGF-beta1), osteopontin (OPN), bone sialo-
protein (BSP), vascular endothelial growth factor (VEGF), matrix
metalloproteinase (MMP)-13, parathormone receptor (PTH-R),
transglutaminase (TG)-2, factor XIIIA (FXIIIA), plasma cell mem-
brane glycoprotein 1 (PC-1) and Ank mRNA levels were quan-
tified using real time RT-PCR. Transglutaminase and nucleotide
triphosphate pyrophosphohydrolase (NTPPPH) activities were
also quantified by enzymatic assays.
Results: MMP-13 (21-fold; p<0.001), OPN (2.8-fold; p<0.001),
TNAP (2-fold, p<0.001), OC (2-fold, p<0.001), TGF-beta1 (1.4-
fold, p<0.01) and VEGF (1,5-fold; p<0.001) gene expression
was significantly higher in sclerotic osteoblasts than in non scle-
rotic cells. In contrast, PTH-R (-37%, p<0.001), PC-1 (-22%,
p <0.01), Ank (-24%, p<0.01) genes were depressed in scle-
rotic osteoblasts compared with non sclerotic cells. Finally, BSP,
TG2 and FXIIIA mRNA levels were similar in sclerotic and non
sclerotic osteoblasts. Transglutaminase activity was increased by
53% in sclerotic osteoblasts (p<0.001), while NTPPPH activity
was decreased by 32% (p<0.001).
Conclusions: Osteoblasts from the sclerotic subchondral bone
showed an altered phenotype characterized by the overexpres-
sion of genes limiting bone mineralization (OPN, PC-1, ...), on
one hand, and genes promoting osteoid matrix accumulation
(TGF-beta1, OC) on the other hand. These findings suggest that
osteoblasts may contribute to subchondral bone sclerosis and as
such constitute a potential target for future OA therapies.
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Purpose: Wnts are secreted signalling molecules, traditionally
associated with developmental processes. Various members of
the Wnt signalling pathway have been implicated in osteogenic
differentiation and high and low bone mass phenotypes. In os-
teoarthritis (OA) there is a massive proliferation of hypominer-
alized trabecular bone. Our hypothesis is that musculoskeletal
cells revert to an earlier, developmental, phenotype and attempt
to produce new matrix inappropriately. We have performed a
pilot study to analyze the role of Wnt signalling in OA by profiling
the expression of Wnt pathway genes in osteoblasts. Bone from
patients with osteoporosis (OP), displaying a low bone mass
phenotype, were used for comparison.
Methods: Femoral heads were obtained from consenting pa-
tients undergoing a total hip replacement for OA (N=5, aged
55-86) or a hemiarthroplasty following a fractured neck of femur
for OP (N=5, aged 68-92). Primary osteoblasts were grown from
bone chips. Total RNA was isolated from cells using Trizol (In-
vitrogen) followed by RNeasy purification (Qiagen) and prepared
for application as biotinylated cRNA to a Wnt pathway Oligo GE
Array (Super Array Biosciences) containing oligo-probes for 128
Wnt-related and housekeeping genes. Intensities were corrected
for background and normalised using the inter-quartile median.
Mean values of signal intensities (medians if not normally dis-
tributed) were found for each disease group, and compared
using analysis of variance. The most highly expressed 30 genes
(∼25%) were examined in each group and the Log2(OA/OP) (sig-
nal log ratio, SLR) calculated and deemed important if greater
than 0.5 or less than -0.5.
Results: The Wnt signalling pathway was clearly active in os-
teoblasts in both dseases. Expression levels for the top 30 genes
were significantly greater than those for the lowest expressed
gene (p<0.05, pairwise comparison, ANOVA on ranks). WISP2,
GSK3A, AES and DVL1 were among the most highly expressed
genes in both diseases and 27 of the top 30 were common to both
groups. High SLR values were found in 7 of these genes, though
no differences in signal between the groups reached statistical
significance at p<0.05. Secreted frizzled related proteins SFRP4
(SLR 0.84) (p=0.056), and SFRP3/FRZB (0.59) were higher in
OA than OP. The Na/H transporter regulator SLC9A3R1/EBP50
(-0.85) and transducin-like enhancers of split TLE1 (-0.51) and
TLE3 (-0.52) were more highly expressed in OP than OA. Of the
Wnt proteins, Wnts 16, 1 and 5a were the most highly expressed
but only WNT5A showed any differential expression with an SLR
of 0.45 (p=0.057).
Conclusions: Wnt signalling is clearly active in elderly bone.
Secreted frizzled-related proteins are extracellular inhibitors of
Wnt signalling and, of particular interest, FRZB has been iden-
tified as a candidate in genetic linkage studies of OA. How-
ever, lower levels of TLEs in OA would indicate higher levels
of gene transcription through the canonical signalling pathway.
The balance between these processes needs further investiga-
tion. Dishevelled-dependent Wnt5a signalling can be transduced
through the RHOA pathway, affecting the cytoskeleton and com-
mitment to cell lineage, and via MAP kinases through the JNK
pathway affecting gene transcription. Higher levels could be a
factor underlying the cellular changes seen in OA.
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Purpose: Aseptic osteonecrosis of the femoral head (ONFH) is
a painful and progressive disorder of the hip, which often leads
to collapse and disabling secondary osteoarthritis of the hip joint.
